ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period
Marinomed Biotech AG: cashflow_financing
One fact, its scope and the complete path back to the official record.
Reported value
2.380M{"amount": 2380200.0, "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities"}- Entity
- Marinomed Biotech AG
- Metric
- cashflow_financing
- Period
- 2021-01-01 – 2021-12-31
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:529900GN3B1EN80XF405:2022-12-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-23T23:30:57.450946+02:00
Raw response SHA-256
dc6e78fa24aab8205f74b7173327f972…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.